Invention Grant
- Patent Title: Genetically altered alfalfa producing clovamide and/or related hydroxycinnamoyl amides
-
Application No.: US15274050Application Date: 2016-09-23
-
Publication No.: US10253324B2Publication Date: 2019-04-09
- Inventor: Michael L Sullivan
- Applicant: The United States of America, as represented by the Secretary of Agriculture
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary of Agriculture
- Current Assignee: The United States of America, as represented by the Secretary of Agriculture
- Current Assignee Address: US DC Washington
- Agent John Fado; David Marks
- Main IPC: C12N15/82
- IPC: C12N15/82 ; C12N9/10 ; A01H1/04 ; C12Q1/6895

Abstract:
Two novel cDNAs for two different genes, HDT1 and HDT2, are isolated from red clover and sequenced. Both HDT1 and HDT2 encode hydroxycinnamoyl-CoA:L-DOPA/tyrosine hydroxycinnamoyl transferase (HDT) which enzymatically produces clovamide and/or related hydroxycinnamoyl amides. Clovamide and related hydroxycinnamoyl amides reduce post-harvest protein degradation. Genetically altered alfalfa plants containing an expression cassette containing a cDNA encoding HDT1 or HDT2 are generated. These genetically altered alfalfa plants produce hydroxycinnamoyl-CoA:L-DOPA/tyrosine hydroxycinnamoyl transferase, which in turn produces clovamide and/or related hydroxycinnamoyl amides.
Public/Granted literature
- US20170088847A1 GENETICALLY ALTERED ALFALFA PRODUCING CLOVAMIDE AND/OR RELATED HYDROXYCINNAMOYL AMIDES Public/Granted day:2017-03-30
Information query
IPC分类: